Reagent recycling scheme acknowledges ‘green’ companies
Hach Lange presents two UK customers with silver bars made from recycled chemical test reagents
Scottish Water and NWL Scientific Services have received silver bars made from recycled test reagents from the firm, which encourages its customers to recycle these products.
Hach Lange has a recycling centre in Germany, which facilitates recovery of toxic materials from reagent tubes, including chemical oxygen demand (COD) cuvettes from which mercury, silver and chromium are recovered. Over 70% of returned materials are either re-used or recycled.
Paul Burton, environmental laboratory manager at NWL Scientific Services, said: ‘As a company we recycle as much as we possibly can and ensure that all used reagents are disposed of as ethically as possible. This is why we fully support Hach Lange’s recycling initiative and gratefully receive the award for our own efforts.’
David McMullan of Scottish Water added: ‘It is a key company ethic of ours to be as environmentally friendly as possible and so it was a natural choice to become involved in Hach Lange’s scheme for recycled COD reagents. We are very pleased to have received this award and would urge other firms within the water industry to adopt similar recycling policies.’
Thousands of cuvette tests are used every day to analyse the contents of liquids in industries such as water, wastewater, manufacturing, food, beverage and power. Hach Lange says its recycling service helps companies comply with waste management regulations and improve environmental performance.
The company was recently commended at The German Sustainability Awards in the Most Sustainable Products and Supply of Services category.
You may also like
Manufacturing
Roquette opens pharmaceutical innovation centre in Brazil
The Health & Pharma Solutions facility in São Paolo offers state-of-the-art laboratories for customers, with the Northeast Center for Strategic Technologies partnering with Roquette to empower young women to pursue careers in science through the Futuras Cientistas programme at the facility
Manufacturing
Samsung Bioepis and Phrontline join forces to advance best-in-class antibody-drug conjugate therapeutics for solid tumours
The pair will co-develop two investigational ADC assets directed against targets expressed in a broad range of cancers, adding a new class of bispecific and dual-payload ADC therapeutics to Samsung Bioepis' oncology portfolio